DLD Asset Management’s Exact Sciences EXAS Stock Holding History

DLD Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,900	Closed	-$701K	–	390
2025 Q4	$701K	Buy	+6,900	New	+$554K	0.05%	206
2025 Q3	–	Sell	-71,900	Closed	-$3.82M	–	372
2025 Q2	$3.82M	Sell	71,900 -6,600	-8%	-$335K	0.32%	58
2025 Q1	$3.4M	Buy	+78,500	New	+$3.98M	0.26%	51

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

DLD Asset Management's EXAS Position: Q1 2026 in Review

DLD Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,900 shares — an estimated $701K sold.

DLD Asset Management first reported a position in EXAS in Q1 2025 and held it in 3 quarters. The position peaked at $3.82M in Q2 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

DLD Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
DLD Asset Management sold 6,900 Exact Sciences shares in Q1 2026, an estimated $701K.
DLD Asset Management first reported a position in Exact Sciences in Q1 2025 and held it in 3 quarters.
DLD Asset Management's Exact Sciences position peaked at $3.82M in Q2 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on DLD Asset Management's 13F filing for Q1 2026, filed 13 May 2026.